NKG2D is critical for tumor elimination (43, 44) and its down-regulation may arise as a consequence of the presence of soluble ligands such as MICA in plasma of cancer patients, a fact that contributes to tumor progression and immune escape (45, 46). The gene discussed is KLRK1; the disease is cancer.